Aims to be a supportive ecosystem for early-stage biotech companies, providing a range of tailored services to help them navigate concept to commercialization.
Growth Direct platform to automate microbial quality control processes for increased efficiency, more robust data integrity, and scalable quality control ops.
A Q&A with Lucy Zhao, manager of the Skin Lab at CPL discusses the importance of in-vitro Release Testing and how it supports topical drug development.
Toxicological evaluation is important at every stage of HPAPI development and manufacturing—CDMOs help ensure new treatments are brought to market safely.